Vitamin D Repletion and AA/EPA Intake in Children with Type 1 Diabetes: Influences on Metabolic Status.
AA/EPA ratio
C-peptide
DHA
EPA
arachidonic acid
omega-3
omega-6
type 1 diabetes
vitamin D
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
01 Nov 2022
01 Nov 2022
Historique:
received:
26
09
2022
revised:
21
10
2022
accepted:
27
10
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
15
11
2022
Statut:
epublish
Résumé
Our study aimed to show a relationship between metabolic control, vitamin D status (25OHD), and arachidonic acid (AA)/eicosapentaenoic acid (EPA) ratio in children with type 1 diabetes (T1D). The secondary aim was to evaluate dietary intake and the presence of ketoacidosis (DKA) at the onset of T1D. Methods: A cohort of 40 children with T1D was recruited, mean age 9.7 years (7.1; 13), with onset of T1D in the last 5 years: some at onset (n: 20, group A) and others after 18.0 ± 5 months (n: 20; group B). Twenty healthy children were compared as control subjects (CS). Dietary intakes were assessed through a diary food frequency questionnaire. Moreover, dried blood spots were used to test AA/EPA ratio by gas chromatography. Results: T1D children had a lower percentage of sugar intake (p < 0.02) than CS. Furthermore, group B introduced a greater amount of AA with the diet (g/day; p < 0.05) than CS (p < 0.01) and group A (p < 0.01). Children with an AA/EPA ratio ≤ 22.5 (1st quartile) required a lower insulin demand and had higher 25OHD levels than those who were in the higher quartiles (p < 0.05). Subjects with DKA (9/40) had levels of 25OHD (p < 0.05) and C-peptide (p < 0.05) lower than those without DKA. Moreover, analyzing the food questionnaire in group A, subjects with DKA showed a lower intake of proteins, sugars, fiber (g/day; p< 0.05), vitamin D, EPA, and DHA (g/day; p < 0.01) compared to subjects without DKA. Non-linear associations between vitamin D intake (p < 0.0001; r2:0.580) and linear between EPA intake and C-peptide (p < 0.05; r: 0.375) were found in all subjects. Conclusions: The study shows a relationship between vitamin D status, AA/EPA ratio, and metabolic state, probably due to their inflammatory and immune mechanisms. A different bromatological composition of the diet could impact the severity of the onset.
Identifiants
pubmed: 36364863
pii: nu14214603
doi: 10.3390/nu14214603
pmc: PMC9655859
pii:
doi:
Substances chimiques
Eicosapentaenoic Acid
AAN7QOV9EA
Arachidonic Acid
27YG812J1I
Vitamin D
1406-16-2
C-Peptide
0
Vitamins
0
Docosahexaenoic Acids
25167-62-8
Fatty Acids, Omega-3
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Nutr Biochem. 2010 May;21(5):444-50
pubmed: 19427777
Am J Clin Nutr. 2003 Dec;78(6):1128-34
pubmed: 14668274
Pediatr Diabetes. 2019 Mar;20(2):172-179
pubmed: 30556249
Metabolites. 2020 Oct 27;10(11):
pubmed: 33120862
Arch Pediatr Adolesc Med. 2012 Jul 1;166(7):601-7
pubmed: 22751874
Diabetes Care. 2004 Dec;27(12):2784-9
pubmed: 15562185
Nutrients. 2019 Sep 11;11(9):
pubmed: 31514368
PLoS One. 2016 Sep 08;11(9):e0162554
pubmed: 27607348
Ital J Pediatr. 2018 May 8;44(1):51
pubmed: 29739471
Diabetologia. 2020 Aug;63(8):1530-1541
pubmed: 32382815
Pediatr Diabetes. 2018 Oct;19 Suppl 27:136-154
pubmed: 30062718
Br J Nutr. 2018 Jan;119(2):163-175
pubmed: 29249211
Clin Diabetes. 2020 Jan;38(1):10-38
pubmed: 31975748
JBMR Plus. 2020 Nov 10;4(12):e10417
pubmed: 33354643
Am J Clin Nutr. 2015 Jun;101(6):1278-85
pubmed: 25948670
Diabetes. 2018 Jan;67(1):146-154
pubmed: 29061729
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Lipids Health Dis. 2010 Jan 27;9:7
pubmed: 20105293
Nutrients. 2013 Sep 12;5(9):3551-62
pubmed: 24036529
Cell Mol Biol (Noisy-le-grand). 2016 Jan 27;62(1):90-8
pubmed: 26828994
Nutr Clin Pract. 2019 Jun;34(3):349-358
pubmed: 30963628
Diabetes Metab Res Rev. 2017 Mar;33(3):
pubmed: 27764529
J Clin Endocrinol Metab. 2020 Dec 1;105(12):
pubmed: 32844222
Clin Immunol. 2015 Dec;161(2):217-24
pubmed: 26277548
J Clin Invest. 2017 May 1;127(5):1757-1771
pubmed: 28375156
Nutrients. 2019 Sep 09;11(9):
pubmed: 31505819
Eur Rev Med Pharmacol Sci. 2022 Sep;26(18):6827-6836
pubmed: 36196731
Diabetes. 2011 May;60(5):1624-31
pubmed: 21441443
J Clin Endocrinol Metab. 2016 Feb;101(2):723-9
pubmed: 26695863
Biochem J. 2017 Mar 24;474(8):1321-1332
pubmed: 28341729
Diabetes Res Clin Pract. 2015 Jun;108(3):e71-5
pubmed: 25836943
Diabetologia. 2011 Nov;54(11):2779-88
pubmed: 21858504
J Lipid Res. 2004 Aug;45(8):1482-92
pubmed: 15145980
Cureus. 2019 Apr 18;11(4):e4497
pubmed: 31259115
Rev Diabet Stud. 2017 Summer-Fall;14(2-3):260-268
pubmed: 29145536
Eur J Clin Nutr. 2016 Jul;70(7):802-7
pubmed: 26908421
Pediatr Endocrinol Diabetes Metab. 2018;2018(3):111-117
pubmed: 30786675
Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):3142-3147
pubmed: 31002167
BMJ. 2022 Jan 26;376:e066452
pubmed: 35082139
J Endocrinol Invest. 2012 Feb;35(2):160-8
pubmed: 21623150
Pediatr Neonatol. 2019 Jun;60(3):237-244
pubmed: 31101452
CellR4 Repair Replace Regen Reprogram. 2018;6(1):
pubmed: 34262992
Rev Endocr Metab Disord. 2020 Mar;21(1):89-116
pubmed: 32180081
Hormones (Athens). 2020 Dec;19(4):453-465
pubmed: 32415650
Diabetes Care. 2013 Jul;36(7):1842-50
pubmed: 23801797
Nutrients. 2019 Dec 03;11(12):
pubmed: 31816979
BMC Res Notes. 2017 Sep 7;10(1):465
pubmed: 28882195
Front Immunol. 2019 Jan 15;9:3160
pubmed: 30697214
JAMA. 2007 Sep 26;298(12):1420-8
pubmed: 17895458